Related Experiment Videos
Lipase supplementation therapy: standards, alternatives, and perspectives
1Department of Medicine, Israelitic Hospital, Hamburg, Germany.
Pancreas
|December 25, 2002
Summary
Lipase supplementation therapy effectively treats steatorrhea, with porcine lipase remaining the standard. Future research explores alternative sources like bacterial lipase for improved lipid digestion in pancreatic exocrine insufficiency.
Area of Science:
- Gastroenterology
- Digestive Physiology
- Pharmacology
Background:
- Steatorrhea treatment has advanced with better understanding of digestive processes.
- Porcine lipase is the established standard for pancreatic exocrine insufficiency.
- Current therapy involves pH-sensitive pancreatin microspheres with specific porcine lipase dosages.
Purpose of the Study:
- To review the pathophysiology of pancreatic exocrine insufficiency.
- To discuss alternative lipase sources beyond porcine origin.
- To explore emerging developments in lipase supplementation therapy.
Main Methods:
- Literature review of current therapeutic concepts and alternative lipase sources.
- Analysis of the efficacy and limitations of existing lipase treatments.
- Discussion of novel approaches including nonporcine lipases and gene therapy.
Main Results:
- Porcine lipase remains the primary treatment, with recommended dosages and strategies for treatment failure.
- Nonporcine lipases (bovine, fungal, bacterial) are evaluated, with bacterial lipase showing promise.
- Advanced options like human pancreatic lipase gene transfer are under development.
Conclusions:
- While porcine lipase is effective, complete normalization of lipid digestion remains a challenge.
- Bacterial lipases represent a promising alternative for future therapeutic applications.
- Ongoing research aims to optimize lipase supplementation for improved patient outcomes.